Atlas Trials

Characterizing Postoperative T and B Cell Dysfunction in Cancer Surgery Patients, Using COVID-19 as a Model Antigen

Clinical trial NCT06925906 · COMPLETED

Trial details

NCT number
NCT06925906
Sponsor
Ottawa Hospital Research Institute
Status
COMPLETED
Study type
OBSERVATIONAL
Abdominal Cancer
Start date
2023-07-05
Primary completion
2024-06-06
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.